跳至主要内容
临床试验/NCT04174651
NCT04174651已完成不适用

The Cerebral Mechanism of Stress-Induced Spontaneous Scratching in Healthy Volunteers and Patients With Atopic Dermatitis (AD)

University of Miami2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2020年1月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
2
主要终点
Changes in brain activity

研究概览

简要总结

The purpose of this study is to examine scratching behavior and identify brain areas responsible for stress-induced spontaneous scratching in patients with atopic dermatitis (AD).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects and AD patients between 18 and 59 years of age.
  • Healthy subjects: In general, good health without history of neurological and psychiatric diseases.
  • AD patients: An average itch rating of 3 out of 10 or greater in the past two weeks using a Numerical Rating Scale (NRS).
  • All patients will be required to cease use of oral antihistamines from the night before each study visit until the end of the experiment. The purpose is to avoid that participants fall asleep during MRI measurement due to side effect oral antihistamine (i.e., sedation).
  • Women of child bearing potential will be administered a pregnancy test to verify that they are not pregnant.
  • MRI Compatibility, criteria include having no major contraindication for MRI (pacemaker, vascular stents, metallic ear tubes, and absence of metal implants or braces) as assessed by MRI technologist using site approved screening form.
  • Participants have to be able to speak and read English fluently.
  • Participants must have signed a written informed consent before being enrolled in the study

排除标准

  • Individuals under 18 or over 59 years of age.
  • Inability to complete the required measures.
  • Suffering from any disease state or physical condition, which would increase their health risk by study participation.
  • Currently enrolled in any investigational study in which the subject is receiving any type of drug, biological, or non-drug therapy.
  • Recent initiation (within last 3 months) of centrally acting agents such as antidepressants, neuroleptics or neuropathic medications.
  • Patients who use centrally acting agents only when they need. The purpose is to avoid a risk of acute effect of these agents on brain activity and perceived stress due to the stress task.
  • Current treatment with opioid analgesics.
  • Uncontrolled thyroid disease.
  • Use of illicit drugs or history of opiate addiction.
  • Diagnosis of a major psychiatric disorder such as schizophrenia, major depression or bipolar disorder that is active right now.
  • Any known diseases or disorders that may affect conducting the experiments (e.g., intracranial pathology, claustrophobia, severe respiratory or cardiovascular problems, active fibromyalgia) or diseases that have potential risks of infections (e.g., HIV, Hepatitis C, etc).
  • Inability to speak and read English.
  • Being pregnant.
  • Incarcerated.

结局指标

主要结局

Changes in brain activity

时间窗: Baseline, 15 minutes

Changes in brain activity will be measured as change in Arterial spin Labeling (ASL) which reflects regional cerebral blood flow. This will be evaluated using functioning magnetic resonance imaging (fMRI).

Change in time of spontaneous scratching

时间窗: Baseline, 15 minutes

Change in spontaneous scratching for behavioral only arms will be calculated by subtracting total duration of scratching behavior before and after the TSST and Landscape video.

次要结局

  • Correlation of perceived stress with stress-induced brain activity(60 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hideki Mochizuki

Assistant Professor

University of Miami

研究点 (2)

Loading locations...

相似试验